2026-05-19T11:35:52Zhttps://keep.lib.asu.edu/oai/request

oai:keep.lib.asu.edu:node-1735352023-04-20T22:31:32Zoai_pmh:alloai_pmh:repo_items

173535 https://hdl.handle.net/10776/1956 2009-01-20 eng Buttar, Aliya Seward, Sheraden Arizona State University. School of Life Sciences. Center for Biology and Society. Embryo Project Encyclopedia. Arizona Board of Regents open access http://creativecommons.org/licenses/by-nc-sa/3.0/ Enovid was the first hormonal birth control pill. G. D. Searle and Company began marketing Enovid as a contraceptive in 1960. The technology was created by the joint efforts of many individuals and organizations, including Margaret Sanger, Katharine McCormick, Gregory Pincus, John Rock, Syntex, S.A. Laboratories, and G.D. Searle and Company Laboratories. Although there were many pieces and contributors to the final product, it was first conceived of and created by Gregory Pincus and Margaret Sanger through the Worcester Foundation in Worcester, Massachusetts, and was distributed by Searle, located in Chicago. This technology is important to the history of embryology because it changed the way people viewed birth control and revolutionized women's birth control methods. There is an extensive literature on the cultural and societal effects of the pill; for example, the effect it had on women's health care and how it changed perceptions of female sexuality. Technology Contraception Reproduction Reproductive Rights Enovid: The First Hormonal Birth Control Pill